Sponsor Pipeline

ADARx Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
7
Recruiting
2
Phase 3
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy		 Trial sites expanded: 27 -> 35 locations
2026-07-28 NCT06989359
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease		 Trial sites expanded: 29 -> 34 locations
Active Trials by Phase
Phase 3
2
Phase 2
3
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06960213 STOP-HAE: A Phase 3 Study of ADX-324 in HAE Hereditary Angioedema Recruiting
NCT07428499 Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE) Hereditary Angioedema (HAE) Recruiting
Phase 2
NCT06989359 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease IgAN Recruiting
NCT07522099 Chinese Adults With Kidney Disease Immunoglobulin A Nephropathy (IgAN) Recruiting
NCT06990269 Phase 2 Study of ADX-038 in Participants With Geographic Atrophy Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting
Phase 1/2
NCT05876312 Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal… Paroxysmal Nocturnal Hemoglobinuria (PNH) Recruiting
NCT05691361 Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema… Hereditary Angioedema Active, Not Recruiting
Phase 1
NCT07081503 Phase 1 Study of ADX-626 in Healthy Participants Healthy Adult Participants Recruiting
NCT06205628 Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Hypertension Active, Not Recruiting
Disease Areas
Hypertension (1) Chronic Kidney Disease (1)
Get alerts when ADARx Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free